Fatigue News and Research

RSS

The long-term effects of SARS-CoV-2 infection on T cell activation: autoimmune disorders and endothelial cell dysfunction

Authors explored the impact of SARS-CoV-2 on thymus (T) cell activation.

1 Aug 2023

What is the relationship between intestinal stem cells and the gut microbiota in regenerative medicine?

Researchers explored the relationship between intestinal stem cells (ISCs) and the gut microbiota and its role in maintaining intestinal health.

1 Aug 2023

Anemia: A global health problem with wide disparities

Anemia affected nearly 2 billion people in 2021, impacting women to a greater degree than men. In a new study covering three decades of global anemia data (1990–2021), a complex picture emerges of how several key factors play into the divergence in success stories among men, women, and children.

31 Jul 2023

NIH launches and opens enrollment for phase 2 clinical trials to evaluate long COVID treatments

Today, the National Institutes of Health launched and is opening enrollment for phase 2 clinical trials that will evaluate at least four potential treatments for long COVID, with additional clinical trials to test at least seven more treatments expected in the coming months.

31 Jul 2023

New technology could help amputees feel temperature in their phantom limbs

Johns Hopkins Applied Physics Laboratory (APL) researchers have developed one of the world's smallest, most intense and fastest refrigeration devices, the wearable thin-film thermoelectric cooler (TFTEC), and teamed with neuroscientists to help amputees perceive a sense of temperature with their phantom limbs.

27 Jul 2023

Research uncovers new insights into post-COVID-19 syndrome (PCS) phenotypes and impact on quality of life

Researchers assessed post-coronavirus disease 2019 (COVID-19) syndrome (PCS) prevalence and severity.

26 Jul 2023

Experts call for urgent mental health support for autoimmune disease patients

More than half of patients with auto-immune conditions experience mental health conditions such as depression or anxiety, yet the majority are rarely or never asked in clinic about mental health symptoms, according to new research from the University of Cambridge and King's College London.

26 Jul 2023

Older sexual and gender minority adults have higher rates of frailty, study shows

In June, the U.S. Census Bureau announced that the average age of the U.S. population reached a new high of nearly 39 years old.

25 Jul 2023

Cognitive impairment following SARS-CoV-2 infection: study adds to existing evidence, but finds important exceptions

A new study evaluated the presence, magnitude, persistence, and correlations of effects in community-based cases.

25 Jul 2023

New AI-based system aims to facilitate the rehabilitation process for stroke patients

Statistics indicate that globally 1 in 4 adults over the age of 25 will have a stroke in their lifetime. One of the most serious consequences of this disease is disability.

24 Jul 2023

Comparing COVID-19 symptom burden and quality of life in positive and negative PCR test results

Reports evaluated to what extent symptoms are present before, during, and after a positive SARS-CoV-2 PCR test.

24 Jul 2023

Community COVID-19 disease is associated with increased risks of post-viral-illness, fatigue, embolism, and respiratory conditions

Researchers determined the magnitude of changes in healthcare utilization attributable to severe acute respiratory syndrome coronavirus 2.

24 Jul 2023

NIAID funds research to better understand Post-treatment Lyme Disease Syndrome

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded five projects for research to better understand Post-treatment Lyme Disease Syndrome (PTLDS), which is a collection of symptoms, such as pain, fatigue, and difficulty thinking or "brain fog," which linger following standard treatment for Lyme disease.

21 Jul 2023

Insights into the pathophysiological mechanisms governing neuropsychiatric symptoms of multiple sclerosis

Researchers pursued insights into the pathophysiological mechanisms governing neuropsychiatric symptoms of MS.

21 Jul 2023

Understanding persistent COVID-19 symptoms: study explores early indicators of long COVID

Researchers investigated early biomarkers of post-acute sequelae of SARS-CoV-2 infection in individuals intensively sampled during the acute phase of COVID-19.

20 Jul 2023

Study explores the effectiveness of caffeine consumption for headaches: trigger or remedy?

Caffeine has a dual role in headaches as it can induces or remediate them.

20 Jul 2023

UC Davis MIND Institute receives 24th consecutive year of NIH funding for FXTAS research

It's been 22 years since UC Davis MIND Institute Medical Director Randi Hagerman and her husband, researcher Paul Hagerman, discovered the neurodegenerative condition called FXTAS (fragile X-associated tremor ataxia syndrome).

19 Jul 2023

Early treatment for multiple sclerosis linked to lower disability risk

People who start taking medication soon after the first signs of multiple sclerosis (MS) may have a lower risk of disability later, according to a study published in the July 19, 2023, online issue of Neurology, the medical journal of the American Academy of Neurology.

19 Jul 2023

A comparison of the lived experiences among extended and long-term young adult cancer survivors

Researchers compared the life experiences of young adult (YA) cancer survivors aged 18 to 39.

18 Jul 2023

Unveiling long COVID: new study explores symptoms and strain variations

Researchers investigated the variation in the clinical and demographic characteristics of acute SARS-CoV-2.

17 Jul 2023

Fatigue News and Research

The long-term effects of SARS-CoV-2 infection on T cell activation: autoimmune disorders and endothelial cell dysfunction

What is the relationship between intestinal stem cells and the gut microbiota in regenerative medicine?

Anemia: A global health problem with wide disparities

NIH launches and opens enrollment for phase 2 clinical trials to evaluate long COVID treatments

New technology could help amputees feel temperature in their phantom limbs

Research uncovers new insights into post-COVID-19 syndrome (PCS) phenotypes and impact on quality of life

Experts call for urgent mental health support for autoimmune disease patients

Older sexual and gender minority adults have higher rates of frailty, study shows

Cognitive impairment following SARS-CoV-2 infection: study adds to existing evidence, but finds important exceptions

New AI-based system aims to facilitate the rehabilitation process for stroke patients

Comparing COVID-19 symptom burden and quality of life in positive and negative PCR test results

Community COVID-19 disease is associated with increased risks of post-viral-illness, fatigue, embolism, and respiratory conditions

NIAID funds research to better understand Post-treatment Lyme Disease Syndrome

Insights into the pathophysiological mechanisms governing neuropsychiatric symptoms of multiple sclerosis

Understanding persistent COVID-19 symptoms: study explores early indicators of long COVID

Study explores the effectiveness of caffeine consumption for headaches: trigger or remedy?

UC Davis MIND Institute receives 24th consecutive year of NIH funding for FXTAS research

Early treatment for multiple sclerosis linked to lower disability risk

A comparison of the lived experiences among extended and long-term young adult cancer survivors

Unveiling long COVID: new study explores symptoms and strain variations

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News